RxDoctor Payments Data

George Berci

West Hollywood, CANPI 1730500273

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $589,823 of the $714,895 with a category attached, or 82.5%. Every reported general payment came from a single manufacturer, KARL Storz Endoscopy-america. Reporting peaked in 2019 at $379,580 and has fallen 79.9% since, to $76,389 in 2023.

$714,895in general payments, 2019–2025

Across 69 payments — averaging $10,361 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KARL Storz Endoscopy-america$715K
$232,155in research payments, 2019–2025

Across 7 payments — averaging $33,165 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • KARL Storz Endoscopy-america$232K

What the payments were for

  • Royalty or licence$114,94916%
  • Consulting fees$589,82383%
  • Grants$2,5000%
  • Travel & lodging$6,7051%
  • Food & beverage$9180%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
KARL Storz Endoscopy-america69$714,895

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →